- Home
- UEIC vs MIST Comparison
UEIC vs MIST Comparison
Compare UEIC & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- MIST
- Stock Information
- Founded
- UEIC 1986
- MIST 2003
- Country
- UEIC United States
- MIST Canada
- Employees
- UEIC N/A
- MIST N/A
- Industry
- UEIC Consumer Electronics/Appliances
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- MIST Health Care
- Exchange
- UEIC Nasdaq
- MIST Nasdaq
- Market Cap
- UEIC 88.0M
- MIST 89.8M
- IPO Year
- UEIC 1993
- MIST N/A
- Fundamental
- Price
- UEIC $6.83
- MIST $1.60
- Analyst Decision
- UEIC Strong Buy
- MIST Strong Buy
- Analyst Count
- UEIC 2
- MIST 2
- Target Price
- UEIC $14.50
- MIST $7.50
- AVG Volume (30 Days)
- UEIC 29.6K
- MIST 1.8M
- Earning Date
- UEIC 08-07-2025
- MIST 08-07-2025
- Dividend Yield
- UEIC N/A
- MIST N/A
- EPS Growth
- UEIC N/A
- MIST N/A
- EPS
- UEIC N/A
- MIST N/A
- Revenue
- UEIC $395,305,000.00
- MIST N/A
- Revenue This Year
- UEIC $3.89
- MIST N/A
- Revenue Next Year
- UEIC $4.35
- MIST N/A
- P/E Ratio
- UEIC N/A
- MIST N/A
- Revenue Growth
- UEIC N/A
- MIST N/A
- 52 Week Low
- UEIC $4.32
- MIST $0.63
- 52 Week High
- UEIC $12.64
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- UEIC 50.84
- MIST 83.15
- Support Level
- UEIC $6.73
- MIST $1.86
- Resistance Level
- UEIC $7.29
- MIST $1.97
- Average True Range (ATR)
- UEIC 0.39
- MIST 0.14
- MACD
- UEIC 0.01
- MIST 0.06
- Stochastic Oscillator
- UEIC 63.78
- MIST 100.00
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).